These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 4595999)

  • 1. [Pathogenicity of Candida albicans of human and bovine origin for mice by intravenous injection].
    Rey M; Fernández-Díez M; Aller B
    Microbiol Esp; 1973; 26(4):179-87. PubMed ID: 4595999
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathogenicity of the Y form as compared to M form in experimentally induced Candida albicans infections.
    Simonetti N; Strippoli V
    Mycopathol Mycol Appl; 1973 Sep; 51(1):19-28. PubMed ID: 4584517
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationship between Candida albicans epidermolytic proteinase activity and virulence in mice.
    Louie A; Dixon DM; el-Maghrabi EA; Burnett JW; Baltch AL; Smith RP
    J Med Vet Mycol; 1994; 32(1):59-64. PubMed ID: 8207623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic infection following intravenous inoculation of mice with Candida albicans int1 mutant strains.
    Bendel CM; Kinneberg KM; Jechorek RP; Gale CA; Erlandsen SL; Hostetter MK; Wells CL
    Mol Genet Metab; 1999 Aug; 67(4):343-51. PubMed ID: 10444345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of pathogenicity of C. albicans. Determination of fifty percent infective dose [ID50] for mice.
    Banerjee U; Kumar R; Mohapatra LN
    Indian J Pathol Microbiol; 1984 Oct; 27(4):289-94. PubMed ID: 6398801
    [No Abstract]   [Full Text] [Related]  

  • 6. The 65 kDa mannoprotein gene of Candida albicans encodes a putative beta-glucanase adhesin required for hyphal morphogenesis and experimental pathogenicity.
    Sandini S; La Valle R; De Bernardis F; Macrì C; Cassone A
    Cell Microbiol; 2007 May; 9(5):1223-38. PubMed ID: 17217426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ecology and epidemiology of Candida species.
    Odds FC
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 Jul; 257(2):207-12. PubMed ID: 6385559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced pathogenicity of Candida albicans pre-treated with subinhibitory concentrations of fluconazole in a mouse model of disseminated candidiasis.
    Navarathna DH; Hornby JM; Hoerrmann N; Parkhurst AM; Duhamel GE; Nickerson KW
    J Antimicrob Chemother; 2005 Dec; 56(6):1156-9. PubMed ID: 16239285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candida albicans strain-dependent virulence and Rim13p-mediated filamentation in experimental keratomycosis.
    Mitchell BM; Wu TG; Jackson BE; Wilhelmus KR
    Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):774-80. PubMed ID: 17251477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenicity in mice of strains of Candida albicans (Robin) Berk. isolated from burn patients.
    Albano MM; Schmitt JA
    Mycopathol Mycol Appl; 1973 Apr; 49(4):283-8. PubMed ID: 4575393
    [No Abstract]   [Full Text] [Related]  

  • 11. High-dose methylprednisolone influences the physiology and virulence of Candida albicans ambiguously and enhances the candidacidal activity of the polyene antibiotic amphotericin B and the superoxide-generating agent menadione.
    Gyetvai A; Emri T; Fekete A; Varga Z; Gazdag Z; Pesti M; Belágyi J; Emõdy L; Pócsi I; Lenkey B
    FEMS Yeast Res; 2007 Mar; 7(2):265-75. PubMed ID: 17266730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative virulence of Candida albicans yeast and filamentous forms in orally and intravenously inoculated mice.
    Bendel CM; Hess DJ; Garni RM; Henry-Stanley M; Wells CL
    Crit Care Med; 2003 Feb; 31(2):501-7. PubMed ID: 12576958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Use of liquid enrichment cultures for the detection of Candida albicans and other incidentally pathogenic yeasts].
    Blaschke-Hellmessen R
    Z Med Lab Diagn; 1977 Feb; 18(1):34-7. PubMed ID: 331710
    [No Abstract]   [Full Text] [Related]  

  • 14. Parameters for determination of Candida albicans virulence in murine peritonitis.
    Kretschmar M; Bertsch T; Göller M; Schaller M; Hof H; Nichterlein T
    Mycoses; 1999; 42 Suppl 2():19-24. PubMed ID: 10865898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of Candida albicans secreted aspartyl proteinase in human vulvovaginal candidiasis.
    Lian CH; Liu WD
    Mycoses; 2007 Sep; 50(5):383-90. PubMed ID: 17714358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Presence of Candida albicans in the vagina following anti-Trichomonas therapy].
    Olszewska D; Pilawski Z; Podkowińska I
    Wiad Parazytol; 1978; 24(4):431-4. PubMed ID: 364842
    [No Abstract]   [Full Text] [Related]  

  • 17. In vitro effect of fibrinogen on Candida albicans germ tube formation.
    Rodrigues A; Vaz CP; Mårdh PA; da Fonseca AF; de Oliveira JM
    APMIS; 1999 Nov; 107(11):1020-2. PubMed ID: 10598874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lower filamentation rates of Candida dubliniensis contribute to its lower virulence in comparison with Candida albicans.
    Stokes C; Moran GP; Spiering MJ; Cole GT; Coleman DC; Sullivan DJ
    Fungal Genet Biol; 2007 Sep; 44(9):920-31. PubMed ID: 17251042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen-dependent induction of persistent vaginal candidosis in naïve mice.
    Hamad M; Abu-Elteen KH; Ghaleb M
    Mycoses; 2004 Aug; 47(7):304-9. PubMed ID: 15310335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Both viable and killed Candida albicans cells induce in vitro production of TNF-alpha and IFN-gamma in murine cells through a TLR2-dependent signalling.
    Murciano C; Yáñez A; Gil ML; Gozalbo D
    Eur Cytokine Netw; 2007 Mar; 18(1):38-43. PubMed ID: 17400537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.